	Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma. Cureus Zamani A, Cohn H, Moser AM, Michael Z, Krinock MJ, Fung G, Shao YF, Ginsburg KB. PMID: 42371453 [PubMed]
	Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies. Target Oncol Valikovics AK, Bacsó D, Samaien N, das Virgens IPA, Szentes B, Agócs G, Obeidat M, Széll T, Hadaschik B, Hegyi P, Nyirády P, Szarvas T. PMID: 42371314 [PubMed - as supplied by publisher]
	Diagnostic performance of bpMRI versus mpMRI and AI-assisted bpMRI in prostate cancer detection: a multi-reader study. Radiol Med Russo L, Bottazzi S, D'Erme L, Avesani G, Di Paola V, Persiani S, Iacono A, Isufi I, Davies L, Arya Z, Mancino M, Lia F, Pallotta G, Sighinolfi MC, Pierconti F, Rocco B, Sala E, Gui B. PMID: 42371294 [PubMed - as supplied by publisher]
	Targeting macrophage-associated core genes for prognostic prediction and therapeutic insights in bladder cancer. Discov Oncol Liu H, Chu Y, Hou J, Wang Y, Li J, Qin J, Liang P, Liao G, Gu P, Liu X, Wen X. PMID: 42371282 [PubMed - as supplied by publisher]
	Imaging response assessment in metastatic renal cell carcinoma: a radiologist's guide to contemporary therapeutic strategies. Abdom Radiol (NY) Withey SJ, Caglic I, Ap Dafydd D, Wicki A, Kelly-Morland C, Sohaib A, Sit C, Remer EM, Kekelidze M. PMID: 42371025 [PubMed - as supplied by publisher]
	Renal CT algorithm for evaluating clear cell carcinoma in solid renal massesâ€‰â‰¤â€‰4Â cm: a retrospective chinese two-center validation study. Abdom Radiol (NY) Zhang N, Li R, Han H, Xiao X, Duan Y, Wang Y. PMID: 42371022 [PubMed - as supplied by publisher]
	Elevated prostate specific antigen due to indwelling urethral catheterisation: myth or fact? A systematic review and meta-analysis. World J Urol Wong HPN, Lau RS, Kyaw L, Parab A, Chen WJK, Loke WT, Chiong E, Law YXT. PMID: 42370958 [PubMed - indexed for MEDLINE]
	The Evaluation of Renal Tumor Diagnostics in Global Pathology Practice. Int J Surg Pathol Y, Farid L, Akbulut D, Malik S, Slisarenko M, Baydar DE, Jikurashvili M, Tjio E, Koy Y, Ertunc O, Kuthi L, Montasser A, Galea L, Lobo A, Korentzelos D, Lagarde-Lenon MS, Yaprak Bayrak B, Biltekin B, Cheng L, Williamson SR, Sangoi AR, Akgul M. PMID: 42370741 [PubMed - as supplied by publisher]
	Serum adipocytokine levels in patients with renal cell carcinoma. Endokrynol Pol S, M, Potyka A, Polok K, Kajdaniuk D, Marek B. PMID: 42370604 [PubMed - as supplied by publisher]
	Renal Cell Carcinoma Metastasis to Cervical Lymph Node: An Unusual Phenomenon Diagnosed by Fine-Needle Aspiration. J Cytol Srinivasan L, Ravi S, Gochhait D, Siddaraju N. PMID: 42370385 [PubMed]
	Choosing neoadjuvant therapy for muscle-invasive bladder cancer based on efficacy-safety trade-off: a network meta-analysis. Front Oncol Zhao Z, Liu X, Zhong Q, Liu L, Pan R, Chen J, Wang X, Liu X, Bao J, Sun Y, Han C, Shi Z, Liang Q. PMID: 42370131 [PubMed]
	Case Report: Decade-delayed thyroid metastasis with cervical lymph node involvement from clear cell renal cell carcinoma: diagnostic pitfalls of cytologic-radiologic discordance. Front Oncol Kang SK, Ryu M, Lee S. PMID: 42370126 [PubMed]
	Assessment of Lymph Node Invasion and Associated Risk Factors in Intermediate-Risk Prostate Cancer: A Retrospective Cross-Sectional Study. Iran J Med Sci Momeni S, Ayati M, Amini E, Inanloo SH, Hamidi Madani M, Hajiasadi E, Ghaderpanah F, Nowroozi MR. PMID: 42370022 [PubMed - indexed for MEDLINE]
	Complete pathological response in patients with bladder cancer: predictors and outcomes. Ther Adv Urol Ghoreifi A, Dudinec JV, Refugia JM, Zahir M, Nabavizadeh R, Shah AM, Abern MR. PMID: 42369179 [PubMed]
	From declared interest to non-participation: a feasibility study of a multi-stage testicular cancer prevention intervention among young men. Front Public Health Pasek M, Wid, , Go, Jochymek M. PMID: 42368918 [PubMed - indexed for MEDLINE]
	The regulatory mechanism and clinical significance of RNA editing in prostate cancer. Curr Urol Li S, Li A, Huang Y, Wang Y, Fan M, Jiang X, Bing K, Liang J, Wang K, Xu Z, Wang L. PMID: 42368672 [PubMed]
	Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer. Front Immunol Ogbonna HN, Norian LA. PMID: 42367819 [PubMed - indexed for MEDLINE]
	MicroRNAs and immunotherapy in testicular germ cell tumors: opportunities and challenges for modulation of the immune microenvironment. Front Immunol Lopez-Saavedra A, Díaz-Chávez J, Jimenez-Ríos MA, Scavuzzo A. PMID: 42367805 [PubMed - indexed for MEDLINE]
	Effectiveness and safety of avelumab maintenance in patients aged â‰¥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study. Front Immunol Roviello G, Gambale E, De Gennaro Aquino I, Maruzzo M, Messina C, Vascotto IA, Rossi V, Bimbatti D, Erbetta E, Messina M, Mennitto A, Rebuzzi SE, Nasso C, Mercinelli C, Catalano M, Maiorano BA, Fanelli M, Sorarù M, Scolari F, Mela MM, Galli L, Salfi A, Rizzo M, Puglisi S, Orlando V, Fornarini G, Rametta A, Giannatempo P, Cerbone L, Doni L, Pillozzi S, Antonuzzo L. PMID: 42367804 [PubMed - indexed for MEDLINE]
	Why CAR T cell therapy fails in renal cell carcinoma. Front Immunol Zhang HJ, Han LZ, Zhang X, Ge YL. PMID: 42367787 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 179558

Page 1 of 8978



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy